Skip to main content
. 2019 Dec 3;122(3):397–404. doi: 10.1038/s41416-019-0670-8

Table 2.

HER1, HER2 and HER3 expression in TNBC by IHC.

Number of patients (%)
HER1 Expression
  Weak (H-Score < 10) 22 (43.1%)
  Moderate (10 ≤ H-Score < 150) 22 (43.1%)
  High (H-Score ≥ 150) 7 (13.8%)
HER2 Expression
  0 40 (78.4%)
  1+ 9 (17.7%)
  2+ 2 (3.9%)
  3+ 0 (0%)
HER3 Expression
  Weak (H-Score < 10) 42 (82.4%)
  Moderate (10 ≤ H-Score < 150) 9 (17.6%)
  High (H-Score ≥ 150) 0 (0%)